William L Herring, PhD

Senior Director, Health Economics
William L Herring
Practice Area:
Therapeutic Expertise:
Headquarters - Research Triangle Park, North Carolina, USA

PhD, Mathematics, Applied (Operations Research)
MSc, Mathematics, Applied
University of Maryland at College Park, College Park, MD

BSc, Mathematics
Davidson College, Davidson, NC

Will Herring, PhD, is a Senior Director in the Health Economics group at RTI-HS and provides a strong interest and extensive background in mathematical modeling and decision analysis across the healthcare system. Over more than a decade with RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his models have been used to inform strategic decisions during the development of new health technologies and to support submissions to healthcare payers and regulatory agencies. Most recently, his research has focused on economic modeling for chronic progressive diseases (Alzheimer’s disease [AD], multiple sclerosis, and nonalcoholic steatohepatitis) and for conditions and interventions affecting elderly populations (AD, herpes zoster vaccination, and respiratory syncytial virus vaccination). Dr. Herring has presented his research on economic modeling and value assessment challenges for AD in multiple national and international settings and is a member of the steering committee for the International Pharmaco-Economic Collaboration for Alzheimer’s Disease (IPECAD) Modelling Group. His therapeutic area experience extends to a range of other therapeutic areas, including ophthalmology (diabetic retinopathy and age-related macular degeneration), respiratory (asthma and chronic obstructive pulmonary disease), dermatology (atopic dermatitis and psoriasis), diabetes, chronic hepatitis C, and oncology. Dr. Herring is a member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the ISPOR Open-Source Modeling Special Interest Group and has presented his work at professional conferences and workshops. His research has been published in peer-reviewed journals, including PharmacoEconomics, Journal of Managed Care and Specialty Pharmacy, and Neurology and Therapy.